+735.2%
MRNA vs XRT
+11.7%
+723.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | XRT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -1.5% | -2.5% | -1.3% |
| 7D | -17.6% | -4.5% | -13.1% | -10.2% |
| 30D | -5.1% | +1.5% | -6.6% | -8.5% |
| 3M | +220.8% | +1.1% | +219.7% | +222.0% |
| 6M | +321.7% | +12.1% | +309.6% | +271.1% |
| YTD | +601.3% | +4.2% | +597.0% | +562.7% |
| 1Y | +735.2% | +13.2% | +722.0% | +611.0% |
| All | +735.2% | +11.7% | +723.5% | +611.0% |
Cumulative growth
Daily Returns
Daily percentage return beside XRT.
Daily Out/Under-Performance
Portfolio return minus XRT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × XRT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded XRT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling